B6.129S2(Cg)-Artm1Fcl/Cnbc

Status

Available to order

EMMA IDEM:06160
Citation informationRRID:IMSR_EM:06160 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129S2(Cg)-Artm1Fcl/Cnbc
Alternative nameSPARKI (SPecificity-affecting AR KnockIn)
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolArtm1Fcl
Gene/Transgene symbolAr

Information from provider

ProviderFrank Claessens
Provider affiliationMolecular and Cellular Medicine, Katholieke Universiteit Leuven
Genetic informationGerm-line knock-in mouse model in which the second zinc-finger of the androgen receptor was replaced with that of the glucocorticoid receptor, resulting in a chimeric protein that retains its ability to bind classical androgen response elements but is unable to bind selective androgen response elements.
Phenotypic informationThe reproductive organs of SPARKI (SPecificity-affecting AR KnockIn) males are smaller compared to wild-type animals, and they are also subfertile. The impaired fertility of the male SPARKI mice correlates with the reduced motility of the spermatozoa.
Breeding historyThe SPARKI mice were backcrossed to a genetic background of >96% C57BL/6 (6 generations). As the mutation is located on the X-chromosome and males are subfertile, the breeding scheme consists of crossing heterozygous females with wild-type males.
References
  • Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model.;Schauwaers Kris, De Gendt Karel, Saunders Philippa T K, Atanassova Nina, Haelens Annemie, Callewaert Leen, Moehren Udo, Swinnen Johannes V, Verhoeven Guido, Verrijdt Guy, Claessens Frank, ;2007;Proceedings of the National Academy of Sciences of the United States of America;104;4961-6; 17360365
  • A role for selective androgen response elements in the development of the epididymis and the androgen control of the 5α reductase II gene.;Kerkhofs Stefanie, Dubois Vanessa, De Gendt Karel, Helsen Christine, Clinckemalie Liesbeth, Spans Lien, Schuit Frans, Boonen Steven, Vanderschueren Dirk, Saunders Philippa T K, Verhoeven Guido, Claessens Frank, ;2012;FASEB journal : official publication of the Federation of American Societies for Experimental Biology;26;4360-72; 22798427
Homozygous fertileno
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivingwild-type C57BL/6J males, heterozygous C57BL/6J females
Stage of embryos2-cell

Disease and phenotype information

MGI phenotypes (gene matching)
  • muscle weakness / MGI
  • increased body weight / MGI
  • female infertility / MGI
  • preneoplasia / MGI
  • no abnormal phenotype detected / MGI
  • increased circulating testosterone level / MGI
  • decreased incidence of tumors by chemical induction / MGI
  • growth/size/body region phenotype / MGI
  • decreased grip strength / MGI
  • mortality/aging / MGI
  • increased urine major urinary protein level / MGI

Literature references

  • Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model.;Schauwaers Kris, De Gendt Karel, Saunders Philippa T K, Atanassova Nina, Haelens Annemie, Callewaert Leen, Moehren Udo, Swinnen Johannes V, Verhoeven Guido, Verrijdt Guy, Claessens Frank, ;2007;Proceedings of the National Academy of Sciences of the United States of America;104;4961-6; 17360365
  • A role for selective androgen response elements in the development of the epididymis and the androgen control of the 5α reductase II gene.;Kerkhofs Stefanie, Dubois Vanessa, De Gendt Karel, Helsen Christine, Clinckemalie Liesbeth, Spans Lien, Schuit Frans, Boonen Steven, Vanderschueren Dirk, Saunders Philippa T K, Verhoeven Guido, Claessens Frank, ;2012;FASEB journal : official publication of the Federation of American Societies for Experimental Biology;26;4360-72; 22798427

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).